塞法兰丁可以通过调节巨细胞极化来缓解脂多糖诱导的急性肺损伤
Longjiao Dang1, Biyao He1, Junjie Yang1
1Key Laboratory of Prescription Effect and Clinical Evaluation of State Administration of Traditional Chinese Medicine of China, School of Pharmacy, Binzhou Medical University, No.346 Guanhai Road, Laishan District, Yantai, 264003, Shandong, China.
Scientific reports
|December 1, 2025
概括
塞法兰丁 (CEP) 通过调节巨细胞两极分化,有效治疗急性肺损伤 (ALI). 这种天然化合物可以减少炎症,并通过特定的分子通路促进肺部恢复.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 呼吸系统医学 呼吸系统医学
背景情况:
- 急性肺损伤 (ALI) 是由炎症驱动的严重呼吸道疾病.
- 巨细胞是影响ALI严重程度和患者结果的关键免疫细胞.
- 塞法兰丁 (CEP) 是一种天然的类化合物,具有抗炎性质.
研究的目的:
- 研究CEP在ALI中的治疗潜力.
- 为了确定CEP是否调节巨细胞两极分化以缓解ALI.
- 阐明CEP对ALI的影响背后的分子机制.
主要方法:
- 组织学分析 (H&E染色) 和生化分析 (ELISA).
- 使用了免疫光和西方斑点技术.
- 进行了体内小鼠模型和体内实验室研究.
主要成果:
- 在ALI小鼠模型中,CEP显著降低了病理变化.
- 在CEP下调的促炎性细胞因子 (IL-6,TNF-α) 和上调的抗炎性IL-10.
- CEP调节了从M1到M2表型的巨细胞极化,抑制了TLR4/MAPK信号传递,并激活了AMPK/Nrf2通路.
结论:
- CEP显示出对脂聚糖类诱导的ALI具有显著的治疗效果.
- CEP调节了巨细胞的两极分化,提供了防止肺损伤的保护机制.
- CEP的行动包括调节TLR4/MAPK和AMPK/Nrf2信号通路.
相关概念视频
Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Dipeptidyl Peptidase 4 Inhibitors
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...


